The purpose of this study is to determine whether ancrod is effective and safe in the treatment of sudden sensorineural hearing loss (SSHL).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
31
Day 1: Intravenous infusion; Days 2, 4, and 6: Subcutaneous injections
Day 1: Intravenous infusion; Days 2, 4, and 6: Subcutaneous injections
Site CZ
Hradec Králové, Czechia
Site CZ
Prague, Czechia
Site D
Göttingen, Germany
Site D
Hamburg, Germany
Site D
Change in PTA (pure tone audiogram) in the affected ear
Time frame: From baseline to Day 8
Change in speech recognition in the affected ear
Time frame: From baseline to Day 8
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hanover, Germany
Site D
Landsberg am Lech, Germany
Site D
München, Germany